EDIT vs ORCL · rev $32.3M vs P/E 31, rev $67.36B
Editas Medicine Inc (EDIT) versus Oracle Corporation (ORCL) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Oracle Corporation (ORCL) is a software - infrastructure company listed on NYSE. It is led by Safra Catz.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported ORCL revenue for 2026-05-31 was $67.36B. Net income was $17.09B. Revenue was up 17.3% from 2025-05-31 to 2026-05-31. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
EDIT currently screens at market cap $375.2M. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
Not investment advice. Open the EDIT and ORCL stock pages for the full models.
Not investment advice.